help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keeton, M.
Right arrow Articles by Loskutoff, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keeton, M.
Right arrow Articles by Loskutoff, D. J.

American Journal of Pathology, Vol 142, 59-70, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue

M Keeton, Y Eguchi, M Sawdey, C Ahn and DJ Loskutoff
Committee on Vascular Biology, Scripps Research Institute, La Jolla, CA 92037.

Type 1 plasminogen activator inhibitor (PAI-1) may be markedly increased in the plasma of patients with endotoxemia and/or renal disease. To investigate renal PAI-1 production during acute endotoxemia, a murine model system was used. Mice were injected with either saline alone or saline containing 50 micrograms endotoxin, and sacrificed 3 hours later and their tissues analyzed for PAI-1 messenger RNA (mRNA) and antigen. Northern blot analysis confirmed that the level of renal PAI-1 mRNA was greatly increased in the endotoxemic mice relative to the saline controls. In situ hybridization was then performed to determine the cellular localization of PAI-1 mRNA within the renal tissues. In the control kidneys, low levels of PAI-1 mRNA were detected in the renal papilla and in the muscular walls of renal arteries. However, in the endotoxemic mice, an intense hybridization signal for PAI-1 mRNA was observed in glomerular and peritubular cells. These cells also stained positively for von Willebrand factor antigen, an endothelial cell-specific marker. The PAI-1 mRNA hybridization signal could further be observed in peritubular endothelial cells in the medulla and in endothelial cells of veins and arteries throughout the kidney. Immunochemical analysis revealed that PAI-1 antigen co- localized to the cytoplasm of cells expressing PAI-1 mRNA. This study provides the first direct evidence that PAI-1 is induced in endothelial cells of the kidney during endotoxemia in vivo and suggests a role for PAI-1 in the pathogenesis of renal disease.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Schafer, K. Muller, A. Hecke, E. Mounier, J. Goebel, D. J. Loskutoff, and S. Konstantinides
Enhanced Thrombosis in Atherosclerosis-Prone Mice Is Associated With Increased Arterial Expression of Plasminogen Activator Inhibitor-1
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2097 - 2103.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Pawlinski, B. Pedersen, B. Kehrle, W. C. Aird, R. D. Frank, M. Guha, and N. Mackman
Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model
Blood, May 15, 2003; 101(10): 3940 - 3947.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Yamamoto, T. Shimokawa, H. Yi, K.-i. Isobe, T. Kojima, D. J. Loskutoff, and H. Saito
Aging Accelerates Endotoxin-Induced Thrombosis : Increased Responses of Plasminogen Activator Inhibitor-1 and Lipopolysaccharide Signaling with Aging
Am. J. Pathol., November 1, 2002; 161(5): 1805 - 1814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. A. Eddy
Plasminogen activator inhibitor-1 and the kidney
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Samad, M. Pandey, and D. J. Loskutoff
Regulation of tissue factor gene expression in obesity
Blood, December 1, 2001; 98(12): 3353 - 3358.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Venugopal, R. Sharon, R. Abramovitz, A. Khasin, and R. Miskin
Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents
Cardiovasc Res, February 1, 2001; 49(2): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kawasaki, M. Dewerchin, H. R. Lijnen, J. Vermylen, and M. F. Hoylaerts
Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice
Blood, July 1, 2000; 96(1): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Samad, K. T. Uysal, S. M. Wiesbrock, M. Pandey, G. S. Hotamisligil, and D. J. Loskutoff
Tumor necrosis factor alpha  is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1
PNAS, June 8, 1999; 96(12): 6902 - 6907.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Yamamoto, V. de Waard, C. Fearns, and D. J. Loskutoff
Tissue Distribution and Regulation of Murine von Willebrand Factor Gene Expression In Vivo
Blood, October 15, 1998; 92(8): 2791 - 2801.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. M. Coffman, R. F. Spurney, R. B. Mannon, and R. Levenson
Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells
Am J Physiol Renal Physiol, August 1, 1998; 275(2): F262 - F269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Yamamoto and D. J. Loskutoff
Extrahepatic Expression and Regulation of Protein C in the Mouse
Am. J. Pathol., August 1, 1998; 153(2): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Samad, M. Pandey, and D. J. Loskutoff
Tissue factor gene expression in the adipose tissues of obese mice
PNAS, June 23, 1998; 95(13): 7591 - 7596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Dong, A. H. Schulick, M. B. DeYoung, and D. A. Dichek
Identification of a cis-Acting Sequence in the Human Plasminogen Activator Inhibitor Type-1 Gene That Mediates Transforming Growth Factor-beta 1 Responsiveness in Endothelium in Vivo
J. Biol. Chem., November 22, 1996; 271(47): 29969 - 29977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. H. Lundgren, S. L. Brown, T. K. Nordt, B. E. Sobel, and S. Fujii
Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes : A Potential Pathogenetic Link Between Obesity and Cardiovascular Disease
Circulation, January 1, 1996; 93(1): 106 - 110.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P.N. Raghunath, J. E. Tomaszewski, S. T. Brady, R. J. Caron, S. S. Okada, and E. S. Barnathan
Plasminogen Activator System in Human Coronary Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1432 - 1443.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. T. Seykora, L. Mei, G. P. Dotto, and P. L. Stein
`Srcasm: a Novel SrcActivating and Signaling Molecule
J. Biol. Chem., January 18, 2002; 277(4): 2812 - 2822.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.